Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wood, G. A.
Right arrow Articles by Archer, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, G. A.
Right arrow Articles by Archer, M. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 7, 1169-1175, July 1999
© 1999 Oxford University Press


Cancer Biology

Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats

Geoffrey A. Wood1, Dittakavi S.R. Sarma2 and Michael C. Archer1,3,

1 Department of Medical Biophysics,
2 Department of Laboratory Medicine and Pathobiology and
3 Department of Nutritional Sciences, University of Toronto, Toronto M5S 3E2, Canada

Previously, we have shown that Copenhagen (Cop) rats are highly resistant to the induction of putative preneoplastic, glutathione S-transferase 7-7 (GST 7-7)-positive liver lesions following treatment with a modified resistant hepatocyte protocol. The objective of the current study was to establish the time course for the development of resistance and examine potential resistance mechanisms in Cop rats using F344 rats as susceptible controls. Male Cop and F344 rats (n = 25), 7–8 weeks of age, were initiated with diethylnitrosamine (200 mg/kg) and promoted 3 weeks later with four doses of 2-acetylaminofluorene (20 mg/kg) and a 2/3 partial hepatectomy (PH). Groups of rats from each strain were killed on days 2, 4, 7, 14 and 21 post-PH, 2 h after receiving bromodeoxyuridine. Cop livers contained similar numbers of GST 7-7-positive lesions to F344 livers on days 2 and 4 post-PH. The percent volume of liver occupied by these lesions did not differ between the strains on days 2, 4 and 7 post-PH. On day 14, however, ~29% of the liver volume in F344 rats was occupied by lesions, whereas in Cop rats this was significantly less (~9%, P < 0.001). On day 21, lesions occupied ~58% of F344 rat livers and only ~6% of Cop livers. Despite these differences, the labeling index of hepatocytes was not significantly different between the strains at any time point, either within lesions or within surrounding normal liver. Furthermore, the apoptotic indices were not different between the strains at any time. However, differences were found in the extent of lesion remodeling (redifferentiation) and in the pattern of oval cell response following PH in Cop livers. By day 14 post-PH, ~76% of Cop liver lesions showed evidence of remodeling, compared with only ~14% of F344 lesions. The oval cell response to PH was equivalent in the two strains up to day 4 post-PH but by day 7, in F344 livers there was extensive migration of these cells into the liver parenchyma, whereas in Cop livers, the response remained localized to the portal regions. These results suggest that Cop resistance occurs at the promotion stage and not the initiation stage of carcinogenesis. Resistance appears not to be due to a lower proliferation rate nor to a higher apoptotic rate within Cop lesions. Precocious remodeling and/or a diminished oval cell response, however, may contribute to the resistance of Cop rats to the growth of GST 7-7-positive hepatic lesions.

Abbreviations: 2-AAF, 2-acetylaminofluorene; AI, apoptotic index; BrdU, 5'-bromodeoxyuridine; Cop, Copenhagen; DEN, diethylnitrosamine; GST 7-7, glutathione S-transferase 7-7; HGF, hepatocyte growth factor; LI, labeling index; PBS, phosphate-buffered saline; PH, 2/3 partial hepatectomy; RH, resistant hepatocyte.

4 To whom correspondence should be addressed at: Department of Nutritional Sciences, Faculty of Medicine, FitzGerald Building, 150 College Street, Toronto M5S 3E2, Canada Email: m.archer{at}utoronto.ca


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
T. P. Ong, R. Heidor, A. de Conti, M. L. Z. Dagli, and F. S. Moreno
Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase
Carcinogenesis, June 1, 2006; 27(6): 1194 - 1203.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. M. de Almeida Vasconcelos Fonseca, C. E. A. Chagas, R. P. Mazzantini, R. Heidor, T. P. Ong, and F. S. Moreno
All-trans and 9-cis retinoic acids, retinol and {beta}-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage
Carcinogenesis, November 1, 2005; 26(11): 1940 - 1946.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. de Moura Espindola, R. P. Mazzantini, T. P. Ong, A. de Conti, R. Heidor, and F. S. Moreno
Geranylgeraniol and {beta}-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-{kappa}B activation
Carcinogenesis, June 1, 2005; 26(6): 1091 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
P. D. Hockings, T. Roberts, S. P. Campbell, D. G. Reid, R. W. Greenhill, S. R. Polley, P. Nelson, T. A. Bertram, and K. Kramer
Longitudinal Magnetic Resonance Imaging Quantitation of Rat Liver Regeneration After Partial Hepatectomy
Toxicol Pathol, August 1, 2002; 30(5): 606 - 610.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
G. A. Wood, J. E. Korkola, and M. C. Archer
Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes
Carcinogenesis, January 1, 2002; 23(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. A. Wood, D. S.R. Sarma, and M. C. Archer
Inheritance of Resistance to Promotion of Preneoplastic Liver Lesions in Copenhagen Rats
Experimental Biology and Medicine, October 1, 2001; 226(9): 831 - 835.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
G. A. Wood and M. C. Archer
Matrix Metalloproteinases-2 and 9 Do Not Play a Role in the Growth of Preneoplastic Liver Lesions in F344 Rats
Experimental Biology and Medicine, September 1, 2001; 226(8): 799 - 803.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. A. Wood, J. E. Korkola, and M. C. Archer
Resistance of Copenhagen rats to hepatocarcinogenesis does not involve T-cell immunity
Carcinogenesis, February 1, 2001; 22(2): 357 - 359.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Kindler-Röhrborn, A. B. Kind, B. U. Koelsch, C. Fischer, and M. F. Rajewsky
Suppression of Ethylnitrosourea-induced Schwannoma Development Involves Elimination of neu/erbB-2 Mutant Premalignant Cells in the Resistant BDIV Rat Strain
Cancer Res., September 1, 2000; 60(17): 4756 - 4760.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.